制限酵素の世界市場:タイプ別(I、II、III、IV)、用途別(遺伝子工学、DNAマッピング、遺伝子配列決定、その他)、エンドタイプ別(スティッキーエンド、ブラントエンド)、ソース別(細菌、古細菌)、切断特異性別(アイソシゾマー、ネオシゾマー)、エンドユーザー別(医薬品・バイオテクノロジー企業、学術研究機関、その他)、地域、競争、予測&機会、2025年Global Restriction Endonuclease Market By Type (I, II, III, IV), By Application (Genetic Engineering, DNA Mapping, Gene Sequencing and Others), By End Type (Sticky End, Blunt End), By Source (Bacteria, Archaea), By Cleavage Specificity (Isoschizomers, Neoschizomers), By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Others), By Region, Competition, Forecast & Opportunities, 2025 制限酵素の世界市場は、予測期間中に圧倒的なCAGRで成長することが予想されます。市場成長の主な要因は、バイオテクノロジー部門や製薬業界などの最終使用産業における研究開発活動への投資の増加です。さらに、... もっと見る
サマリー制限酵素の世界市場は、予測期間中に圧倒的なCAGRで成長することが予想されます。市場成長の主な要因は、バイオテクノロジー部門や製薬業界などの最終使用産業における研究開発活動への投資の増加です。さらに、糖尿病や癌などの慢性的な健康障害の発生率の増加は、今後数年間で世界中の制限酵素市場の成長に良い影響を与えると予測されています。さらに、資金提供という点での政府支援の増加が、2025年までの市場成長を後押しすると予測されています。制限酵素の世界市場は、タイプ、アプリケーション、エンドタイプ、ソース、切断、エンドユーザー、地域、企業に基づいて区分されます。タイプに基づいて、市場はタイプI、タイプII、タイプIII、タイプIVに分けることができます。そのうち、タイプIIセグメントは2019年まで最大の市場規模という点で市場を支配し、さらに予測期間中もそのリードを維持すると予想されます。この成長は、遺伝子クローニングやDNA断片化、分析など、日常的に行われる分子生物学的な用途で使用されていることに起因しています。また、これらの酵素はDNAを一定の位置で切断するため、小さく明確なDNA断片が生成され、遺伝子やゲノムの特性解析に役立つことから、今後数年間、タイプII制限酵素の成長を後押しすると予想されています。さらに、バイオテクノロジー企業による開発活動への投資の増加が、このセグメントの成長をさらに後押ししています。 制限酵素の世界市場で事業を展開している主な企業は、New England Biolabs、Thermo Fisher Scientific、Takara Bio、Sigma-Aldrich、Illumina、Agilent Technologies、Promega、Jena Biosciences、Genetix Biotech Asia Pvt.世界中の制限酵素市場で動作する企業は、市場でのシェアを拡大に向かってより焦点を当てています。例えば、これらの主要なプレーヤーは、ユーザーの要件を満たすために、新規技術の開発などの有機的な戦略を行っており、業界の高い競争力を作るために。 本レポートで考慮した年数 歴史的年数:2015年~2018年 基本年:2019年 推定年:2020年 予測年:2021年~2025年 本調査の目的 - 世界の制限酵素市場の市場規模を分析・予測する。 - タイプ、アプリケーション、エンドタイプ、ソース、切断、エンドユーザー、企業、地域分布に基づいて、世界の制限エンドヌクレアーゼ市場を分類・予測する。 - 世界の制限エンドヌクレアーゼ市場の促進要因と課題を特定する。 - 世界の制限酵素市場における拡張、新製品発表、M&Aなどの競合開発を調査する。 - 世界の制限酵素市場の価格分析を行う。 - 世界の制限酵素市場で活動する主要企業のプロフィールを特定し、分析する。 TechSci Researchはこの調査のために一次調査と徹底的な二次調査の両方を実施しました。当初、TechSci Researchは世界中の企業のリストを入手しました。その後、TechSci Researchは特定された企業に対して一次調査の調査を実施した。インタビューしながら、回答者には競合他社についても質問しました。この手法により、TechSci Research は、二次調査の制限により特定できなかった企業も含めることができました。TechSci Research は、新製品、販売チャネル、世界中のすべての主要なプレーヤーの存在を分析しました。 TechSci Researchは、様々なエンドユーザーセグメントのデータを記録し、将来的な予測を行うボトムアップアプローチを用いて、世界の制限酵素市場の市場規模を算出した。TechSci Researchは、これらの値を業界の専門家や企業の代表者から入手し、適切で全体的な市場規模を得るためにこれらの製品タイプやアプリケーションの履歴データの分析を通じて外部で検証しました。企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家向けプレゼンテーション、財務報告書など、さまざまな二次資料もTechSci Researchによって調査されました。 主な対象読者 - 制限酵素の企業およびその他の利害関係者 - 規制当局や政策立案者などの政府機関 - 制限酵素に関連する組織、フォーラム、アライアンス - 市場調査会社およびコンサルティング会社 本調査は、企業やパートナー、エンドユーザーなどの業界関係者にとって重要ないくつかの重要な質問に対する回答を提供し、さらに投資の戦略や市場機会の活用を可能にする上で有用です。 レポートの範囲 本レポートでは、制限酵素の世界市場を、以下に詳述した業界動向に加えて、以下のカテゴリーに分類しています。 - 市場、タイプ別 o タイプI o タイプII o タイプIII o タイプIV - 市場、アプリケーション別 o 遺伝子工学 o DNAマッピング o 遺伝子シークエンス o その他 - 市場、エンドタイプ別 o Sticky End o Blunt End - 市場、ソース別 o バクテリア o 古細菌 - 市場、開裂特異性別 o イソシキゾマー ネオシゾマー - 市場、エンドユーザー別 o 製薬会社、バイオテクノロジー会社 o アカデミックリサーチインスティチュート o その他 - 市場、地域別 o 北米 米国 メキシコ カナダ o ヨーロッパ ドイツ フランス イギリス イタリア スペイン o アジア太平洋地域 中国 インド 日本 韓国 オーストラリア シンガポール o 中東・アフリカ 南アフリカ共和国 サウジアラビア UAE o 南米 ブラジル アルゼンチン コロンビア 競合他社の状況 企業プロファイル。制限酵素の世界市場における主要企業の詳細分析。 利用可能なカスタマイズ。 TechSci Researchでは、与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供しています。このレポートでは、以下のカスタマイズが可能です。 企業情報 - 追加的な市場プレイヤーの詳細分析とプロファイリング(最大5社まで)。 目次1. Product Overview2. Research Methodology 3. Impact of COVID-19 on Global Restriction Endonuclease Market 4. Executive Summary 5. Global Restriction Endonuclease Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value & Volume 5.2. Market Share & Forecast 5.2.1. By Type (I, II, III, IV) 5.2.2. By Application ( Genetic Engineering, DNA Mapping, Gene Sequencing and Others) 5.2.3. By End Type (Sticky End, Blunt End) 5.2.4. By Source (Bacteria, Archaea) 5.2.5. By Cleavage Specificity (Isoschizomers, Neoschizomers) 5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Others) 5.2.7. By Company (2019) 5.2.8. By Region 5.3. Market Attractiveness Index 6. Asia-Pacific Restriction Endonuclease Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value & Volume 6.2. Market Share & Forecast 6.2.1. By Type 6.2.2. By Application 6.2.3. By End Type 6.2.4. By Source 6.2.5. By Cleavage Specificity 6.2.6. By End-User 6.2.7. By Country 6.3. Market Attractiveness Index 6.4. Asia-Pacific: Country Analysis 6.4.1. China Restriction Endonuclease Market Outlook 6.4.1.1. Market Size & Forecast 6.4.1.1.1. By Value 6.4.1.2. Market Share & Forecast 6.4.1.2.1. By Type 6.4.1.2.2. By Application 6.4.1.2.3. By End Type 6.4.1.2.4. By Source 6.4.1.2.5. By Cleavage Specificity 6.4.1.2.6. By End-User 6.4.2. India Restriction Endonuclease Market Outlook 6.4.2.1. Market Size & Forecast 6.4.2.1.1. By Value 6.4.2.2. Market Share & Forecast 6.4.2.2.1. By Type 6.4.2.2.2. By Application 6.4.2.2.3. By End Type 6.4.2.2.4. By Source 6.4.2.2.5. By Cleavage Specificity 6.4.2.2.6. By End-User 6.4.3. Japan Restriction Endonuclease Market Outlook 6.4.3.1. Market Size & Forecast 6.4.3.1.1. By Value 6.4.3.2. Market Share & Forecast 6.4.3.2.1. By Type 6.4.3.2.2. By Application 6.4.3.2.3. By End Type 6.4.3.2.4. By Source 6.4.3.2.5. By Cleavage Specificity 6.4.3.2.6. By End-User 6.4.4. South Korea Restriction Endonuclease Market Outlook 6.4.4.1. Market Size & Forecast 6.4.4.1.1. By Value 6.4.4.2. Market Share & Forecast 6.4.4.2.1. By Type 6.4.4.2.2. By Application 6.4.4.2.3. By End Type 6.4.4.2.4. By Source 6.4.4.2.5. By Cleavage Specificity 6.4.4.2.6. By End-User 6.4.5. Singapore Restriction Endonuclease Market Outlook 6.4.5.1. Market Size & Forecast 6.4.5.1.1. By Value 6.4.5.2. Market Share & Forecast 6.4.5.2.1. By Type 6.4.5.2.2. By Application 6.4.5.2.3. By End Type 6.4.5.2.4. By Source 6.4.5.2.5. By Cleavage Specificity 6.4.5.2.6. By End-User 6.4.6. Australia Restriction Endonuclease Market Outlook 6.4.6.1. Market Size & Forecast 6.4.6.1.1. By Value 6.4.6.2. Market Share & Forecast 6.4.6.2.1. By Type 6.4.6.2.2. By Application 6.4.6.2.3. By End Type 6.4.6.2.4. By Source 6.4.6.2.5. By Cleavage Specificity 6.4.6.2.6. By End-User 7. Europe Restriction Endonuclease Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value & Volume 7.2. Market Share & Forecast 7.2.1. By Type 7.2.2. By Application 7.2.3. By End Type 7.2.4. By Source 7.2.5. By Cleavage Specificity 7.2.6. By End-User 7.2.7. By Country 7.3. Market Attractiveness Index 7.4. Europe: Country Analysis 7.4.1. France Restriction Endonuclease Market Outlook 7.4.1.1. Market Size & Forecast 7.4.1.1.1. By Value 7.4.1.2. Market Share & Forecast 7.4.1.2.1. By Type 7.4.1.2.2. By Application 7.4.1.2.3. By End Type 7.4.1.2.4. By Source 7.4.1.2.5. By Cleavage Specificity 7.4.1.2.6. By End-User 7.4.2. Germany Restriction Endonuclease Market Outlook 7.4.2.1. Market Size & Forecast 7.4.2.1.1. By Value 7.4.2.2. Market Share & Forecast 7.4.2.2.1. By Type 7.4.2.2.2. By Application 7.4.2.2.3. By End Type 7.4.2.2.4. By Source 7.4.2.2.5. By Cleavage Specificity 7.4.2.2.6. By End-User 7.4.3. United Kingdom Restriction Endonuclease Market Outlook 7.4.3.1. Market Size & Forecast 7.4.3.1.1. By Value 7.4.3.2. Market Share & Forecast 7.4.3.2.1. By Type 7.4.3.2.2. By Application 7.4.3.2.3. By End Type 7.4.3.2.4. By Source 7.4.3.2.5. By Cleavage Specificity 7.4.3.2.6. By End-User 7.4.4. Italy Restriction Endonuclease Market Outlook 7.4.4.1. Market Size & Forecast 7.4.4.1.1. By Value 7.4.4.2. Market Share & Forecast 7.4.4.2.1. By Type 7.4.4.2.2. By Application 7.4.4.2.3. By End Type 7.4.4.2.4. By Source 7.4.4.2.5. By Cleavage Specificity 7.4.4.2.6. By End-User 7.4.5. Spain Restriction Endonuclease Market Outlook 7.4.5.1. Market Size & Forecast 7.4.5.1.1. By Value 7.4.5.2. Market Share & Forecast 7.4.5.2.1. By Type 7.4.5.2.2. By Application 7.4.5.2.3. By End Type 7.4.5.2.4. By Source 7.4.5.2.5. By Cleavage Specificity 7.4.5.2.6. By End-User 8. North America Restriction Endonuclease Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value & Volume 8.2. Market Share & Forecast 8.2.1. By Type 8.2.2. By Application 8.2.3. By End Type 8.2.4. By Source 8.2.5. By Cleavage Specificity 8.2.6. By End-User 8.2.7. By Country 8.3. Market Attractiveness Index 8.4. North America: Country Analysis 8.4.1. United States Restriction Endonuclease Market Outlook 8.4.1.1. Market Size & Forecast 8.4.1.1.1. By Value 8.4.1.2. Market Share & Forecast 8.4.1.2.1. By Type 8.4.1.2.2. By Application 8.4.1.2.3. By End Type 8.4.1.2.4. By Source 8.4.1.2.5. By Cleavage Specificity 8.4.1.2.6. By End-User 8.4.2. Mexico Restriction Endonuclease Market Outlook 8.4.2.1. Market Size & Forecast 8.4.2.1.1. By Value 8.4.2.2. Market Share & Forecast 8.4.2.2.1. By Type 8.4.2.2.2. By Application 8.4.2.2.3. By End Type 8.4.2.2.4. By Source 8.4.2.2.5. By Cleavage Specificity 8.4.2.2.6. By End-User 8.4.3. Canada Restriction Endonuclease Market Outlook 8.4.3.1. Market Size & Forecast 8.4.3.1.1. By Value 8.4.3.2. Market Share & Forecast 8.4.3.2.1. By Type 8.4.3.2.2. By Application 8.4.3.2.3. By End Type 8.4.3.2.4. By Source 8.4.3.2.5. By Cleavage Specificity 8.4.3.2.6. By End-User 9. South America Restriction Endonuclease Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value & Volume 9.2. Market Share & Forecast 9.2.1. By Type 9.2.2. By Application 9.2.3. By End Type 9.2.4. By Source 9.2.5. By Cleavage Specificity 9.2.6. By End-User 9.2.7. By Country 9.3. Market Attractiveness Index 9.4. South America: Country Analysis 9.4.1. Brazil Restriction Endonuclease Market Outlook 9.4.1.1. Market Size & Forecast 9.4.1.1.1. By Value 9.4.1.2. Market Share & Forecast 9.4.1.2.1. By Type 9.4.1.2.2. By Application 9.4.1.2.3. By End Type 9.4.1.2.4. By Source 9.4.1.2.5. By Cleavage Specificity 9.4.1.2.6. By End-User 9.4.2. Argentina Restriction Endonuclease Market Outlook 9.4.2.1. Market Size & Forecast 9.4.2.1.1. By Value 9.4.2.2. Market Share & Forecast 9.4.2.2.1. By Type 9.4.2.2.2. By Application 9.4.2.2.3. By End Type 9.4.2.2.4. By Source 9.4.2.2.5. By Cleavage Specificity 9.4.2.2.6. By End-User 9.4.3. Colombia Restriction Endonuclease Market Outlook 9.4.3.1. Market Size & Forecast 9.4.3.1.1. By Value 9.4.3.2. Market Share & Forecast 9.4.3.2.1. By Type 9.4.3.2.2. By Application 9.4.3.2.3. By End Type 9.4.3.2.4. By Source 9.4.3.2.5. By Cleavage Specificity 9.4.3.2.6. By End-User 10. Middle East and Africa Restriction Endonuclease Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value & Volume 10.2. Market Share & Forecast 10.2.1. By Type 10.2.2. By Application 10.2.3. By End Type 10.2.4. By Source 10.2.5. By Cleavage Specificity 10.2.6. By End-User 10.2.7. By Country 10.3. Market Attractiveness Index 10.4. MEA: Country Analysis 10.4.1. South Africa Restriction Endonuclease Market Outlook 10.4.1.1. Market Size & Forecast 10.4.1.1.1. By Value 10.4.1.2. Market Share & Forecast 10.4.1.2.1. By Type 10.4.1.2.2. By Application 10.4.1.2.3. By End Type 10.4.1.2.4. By Source 10.4.1.2.5. By Cleavage Specificity 10.4.1.2.6. By End-User 10.4.2. Saudi Arabia Restriction Endonuclease Market Outlook 10.4.2.1. Market Size & Forecast 10.4.2.1.1. By Value 10.4.2.2. Market Share & Forecast 10.4.2.2.1. By Type 10.4.2.2.2. By Application 10.4.2.2.3. By End Type 10.4.2.2.4. By Source 10.4.2.2.5. By Cleavage Specificity 10.4.2.2.6. By End-User 10.4.3. UAE Restriction Endonuclease Market Outlook 10.4.3.1. Market Size & Forecast 10.4.3.1.1. By Value 10.4.3.2. Market Share & Forecast 10.4.3.2.1. By Type 10.4.3.2.2. By Application 10.4.3.2.3. By End Type 10.4.3.2.4. By Source 10.4.3.2.5. By Cleavage Specificity 10.4.3.2.6. By End-User 11. Market Dynamics 11.1. Drivers 11.2. Challenges 12. Market Trends & Developments 13. Competitive Landscape 13.1. Competition Outlook 13.2. Players Profiled (Leading Companies) 13.2.1. New England Biolabs 13.2.2. Thermo Fisher Scientific 13.2.3. Takara Bio 13.2.4. Sigma-Aldrich 13.2.5. Illumina 13.2.6. Agilent Technologies 13.2.7. Promega 13.2.8. Jena Biosciences 13.2.9. Genetix Biotech Asia Pvt. Ltd. 13.2.10. Roche 13.2.11. Merck 13.2.12. Pfizer 13.2.13. Amgen 13.2.14. Vertex Pharmaceuticals 13.2.15. BioMarin Pharmaceutical 13.2.16. PerkinElmer 13.2.17. Abcam 13.2.18. Abbexa 13.2.19. Sisco Research Laboratories Pvt Ltd 13.2.20. Nippon Gene 14. Strategic Recommendations 15. About Us & Disclaimer
SummaryGlobal restriction endonuclease market is expected to grow at a formidable CAGR during the forecast period. The key factor responsible for market growth is growing investment in research and development activities in end use industries such as biotechnology sector and pharmaceutical industry. Additionally, rising incidences of chronic health disorders like diabetes, cancer among others is anticipated to bode well for the growth of restriction endonuclease market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is projected to bolster the market growth through 2025. Table of Contents1. Product Overview2. Research Methodology 3. Impact of COVID-19 on Global Restriction Endonuclease Market 4. Executive Summary 5. Global Restriction Endonuclease Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value & Volume 5.2. Market Share & Forecast 5.2.1. By Type (I, II, III, IV) 5.2.2. By Application ( Genetic Engineering, DNA Mapping, Gene Sequencing and Others) 5.2.3. By End Type (Sticky End, Blunt End) 5.2.4. By Source (Bacteria, Archaea) 5.2.5. By Cleavage Specificity (Isoschizomers, Neoschizomers) 5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Others) 5.2.7. By Company (2019) 5.2.8. By Region 5.3. Market Attractiveness Index 6. Asia-Pacific Restriction Endonuclease Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value & Volume 6.2. Market Share & Forecast 6.2.1. By Type 6.2.2. By Application 6.2.3. By End Type 6.2.4. By Source 6.2.5. By Cleavage Specificity 6.2.6. By End-User 6.2.7. By Country 6.3. Market Attractiveness Index 6.4. Asia-Pacific: Country Analysis 6.4.1. China Restriction Endonuclease Market Outlook 6.4.1.1. Market Size & Forecast 6.4.1.1.1. By Value 6.4.1.2. Market Share & Forecast 6.4.1.2.1. By Type 6.4.1.2.2. By Application 6.4.1.2.3. By End Type 6.4.1.2.4. By Source 6.4.1.2.5. By Cleavage Specificity 6.4.1.2.6. By End-User 6.4.2. India Restriction Endonuclease Market Outlook 6.4.2.1. Market Size & Forecast 6.4.2.1.1. By Value 6.4.2.2. Market Share & Forecast 6.4.2.2.1. By Type 6.4.2.2.2. By Application 6.4.2.2.3. By End Type 6.4.2.2.4. By Source 6.4.2.2.5. By Cleavage Specificity 6.4.2.2.6. By End-User 6.4.3. Japan Restriction Endonuclease Market Outlook 6.4.3.1. Market Size & Forecast 6.4.3.1.1. By Value 6.4.3.2. Market Share & Forecast 6.4.3.2.1. By Type 6.4.3.2.2. By Application 6.4.3.2.3. By End Type 6.4.3.2.4. By Source 6.4.3.2.5. By Cleavage Specificity 6.4.3.2.6. By End-User 6.4.4. South Korea Restriction Endonuclease Market Outlook 6.4.4.1. Market Size & Forecast 6.4.4.1.1. By Value 6.4.4.2. Market Share & Forecast 6.4.4.2.1. By Type 6.4.4.2.2. By Application 6.4.4.2.3. By End Type 6.4.4.2.4. By Source 6.4.4.2.5. By Cleavage Specificity 6.4.4.2.6. By End-User 6.4.5. Singapore Restriction Endonuclease Market Outlook 6.4.5.1. Market Size & Forecast 6.4.5.1.1. By Value 6.4.5.2. Market Share & Forecast 6.4.5.2.1. By Type 6.4.5.2.2. By Application 6.4.5.2.3. By End Type 6.4.5.2.4. By Source 6.4.5.2.5. By Cleavage Specificity 6.4.5.2.6. By End-User 6.4.6. Australia Restriction Endonuclease Market Outlook 6.4.6.1. Market Size & Forecast 6.4.6.1.1. By Value 6.4.6.2. Market Share & Forecast 6.4.6.2.1. By Type 6.4.6.2.2. By Application 6.4.6.2.3. By End Type 6.4.6.2.4. By Source 6.4.6.2.5. By Cleavage Specificity 6.4.6.2.6. By End-User 7. Europe Restriction Endonuclease Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value & Volume 7.2. Market Share & Forecast 7.2.1. By Type 7.2.2. By Application 7.2.3. By End Type 7.2.4. By Source 7.2.5. By Cleavage Specificity 7.2.6. By End-User 7.2.7. By Country 7.3. Market Attractiveness Index 7.4. Europe: Country Analysis 7.4.1. France Restriction Endonuclease Market Outlook 7.4.1.1. Market Size & Forecast 7.4.1.1.1. By Value 7.4.1.2. Market Share & Forecast 7.4.1.2.1. By Type 7.4.1.2.2. By Application 7.4.1.2.3. By End Type 7.4.1.2.4. By Source 7.4.1.2.5. By Cleavage Specificity 7.4.1.2.6. By End-User 7.4.2. Germany Restriction Endonuclease Market Outlook 7.4.2.1. Market Size & Forecast 7.4.2.1.1. By Value 7.4.2.2. Market Share & Forecast 7.4.2.2.1. By Type 7.4.2.2.2. By Application 7.4.2.2.3. By End Type 7.4.2.2.4. By Source 7.4.2.2.5. By Cleavage Specificity 7.4.2.2.6. By End-User 7.4.3. United Kingdom Restriction Endonuclease Market Outlook 7.4.3.1. Market Size & Forecast 7.4.3.1.1. By Value 7.4.3.2. Market Share & Forecast 7.4.3.2.1. By Type 7.4.3.2.2. By Application 7.4.3.2.3. By End Type 7.4.3.2.4. By Source 7.4.3.2.5. By Cleavage Specificity 7.4.3.2.6. By End-User 7.4.4. Italy Restriction Endonuclease Market Outlook 7.4.4.1. Market Size & Forecast 7.4.4.1.1. By Value 7.4.4.2. Market Share & Forecast 7.4.4.2.1. By Type 7.4.4.2.2. By Application 7.4.4.2.3. By End Type 7.4.4.2.4. By Source 7.4.4.2.5. By Cleavage Specificity 7.4.4.2.6. By End-User 7.4.5. Spain Restriction Endonuclease Market Outlook 7.4.5.1. Market Size & Forecast 7.4.5.1.1. By Value 7.4.5.2. Market Share & Forecast 7.4.5.2.1. By Type 7.4.5.2.2. By Application 7.4.5.2.3. By End Type 7.4.5.2.4. By Source 7.4.5.2.5. By Cleavage Specificity 7.4.5.2.6. By End-User 8. North America Restriction Endonuclease Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value & Volume 8.2. Market Share & Forecast 8.2.1. By Type 8.2.2. By Application 8.2.3. By End Type 8.2.4. By Source 8.2.5. By Cleavage Specificity 8.2.6. By End-User 8.2.7. By Country 8.3. Market Attractiveness Index 8.4. North America: Country Analysis 8.4.1. United States Restriction Endonuclease Market Outlook 8.4.1.1. Market Size & Forecast 8.4.1.1.1. By Value 8.4.1.2. Market Share & Forecast 8.4.1.2.1. By Type 8.4.1.2.2. By Application 8.4.1.2.3. By End Type 8.4.1.2.4. By Source 8.4.1.2.5. By Cleavage Specificity 8.4.1.2.6. By End-User 8.4.2. Mexico Restriction Endonuclease Market Outlook 8.4.2.1. Market Size & Forecast 8.4.2.1.1. By Value 8.4.2.2. Market Share & Forecast 8.4.2.2.1. By Type 8.4.2.2.2. By Application 8.4.2.2.3. By End Type 8.4.2.2.4. By Source 8.4.2.2.5. By Cleavage Specificity 8.4.2.2.6. By End-User 8.4.3. Canada Restriction Endonuclease Market Outlook 8.4.3.1. Market Size & Forecast 8.4.3.1.1. By Value 8.4.3.2. Market Share & Forecast 8.4.3.2.1. By Type 8.4.3.2.2. By Application 8.4.3.2.3. By End Type 8.4.3.2.4. By Source 8.4.3.2.5. By Cleavage Specificity 8.4.3.2.6. By End-User 9. South America Restriction Endonuclease Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value & Volume 9.2. Market Share & Forecast 9.2.1. By Type 9.2.2. By Application 9.2.3. By End Type 9.2.4. By Source 9.2.5. By Cleavage Specificity 9.2.6. By End-User 9.2.7. By Country 9.3. Market Attractiveness Index 9.4. South America: Country Analysis 9.4.1. Brazil Restriction Endonuclease Market Outlook 9.4.1.1. Market Size & Forecast 9.4.1.1.1. By Value 9.4.1.2. Market Share & Forecast 9.4.1.2.1. By Type 9.4.1.2.2. By Application 9.4.1.2.3. By End Type 9.4.1.2.4. By Source 9.4.1.2.5. By Cleavage Specificity 9.4.1.2.6. By End-User 9.4.2. Argentina Restriction Endonuclease Market Outlook 9.4.2.1. Market Size & Forecast 9.4.2.1.1. By Value 9.4.2.2. Market Share & Forecast 9.4.2.2.1. By Type 9.4.2.2.2. By Application 9.4.2.2.3. By End Type 9.4.2.2.4. By Source 9.4.2.2.5. By Cleavage Specificity 9.4.2.2.6. By End-User 9.4.3. Colombia Restriction Endonuclease Market Outlook 9.4.3.1. Market Size & Forecast 9.4.3.1.1. By Value 9.4.3.2. Market Share & Forecast 9.4.3.2.1. By Type 9.4.3.2.2. By Application 9.4.3.2.3. By End Type 9.4.3.2.4. By Source 9.4.3.2.5. By Cleavage Specificity 9.4.3.2.6. By End-User 10. Middle East and Africa Restriction Endonuclease Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value & Volume 10.2. Market Share & Forecast 10.2.1. By Type 10.2.2. By Application 10.2.3. By End Type 10.2.4. By Source 10.2.5. By Cleavage Specificity 10.2.6. By End-User 10.2.7. By Country 10.3. Market Attractiveness Index 10.4. MEA: Country Analysis 10.4.1. South Africa Restriction Endonuclease Market Outlook 10.4.1.1. Market Size & Forecast 10.4.1.1.1. By Value 10.4.1.2. Market Share & Forecast 10.4.1.2.1. By Type 10.4.1.2.2. By Application 10.4.1.2.3. By End Type 10.4.1.2.4. By Source 10.4.1.2.5. By Cleavage Specificity 10.4.1.2.6. By End-User 10.4.2. Saudi Arabia Restriction Endonuclease Market Outlook 10.4.2.1. Market Size & Forecast 10.4.2.1.1. By Value 10.4.2.2. Market Share & Forecast 10.4.2.2.1. By Type 10.4.2.2.2. By Application 10.4.2.2.3. By End Type 10.4.2.2.4. By Source 10.4.2.2.5. By Cleavage Specificity 10.4.2.2.6. By End-User 10.4.3. UAE Restriction Endonuclease Market Outlook 10.4.3.1. Market Size & Forecast 10.4.3.1.1. By Value 10.4.3.2. Market Share & Forecast 10.4.3.2.1. By Type 10.4.3.2.2. By Application 10.4.3.2.3. By End Type 10.4.3.2.4. By Source 10.4.3.2.5. By Cleavage Specificity 10.4.3.2.6. By End-User 11. Market Dynamics 11.1. Drivers 11.2. Challenges 12. Market Trends & Developments 13. Competitive Landscape 13.1. Competition Outlook 13.2. Players Profiled (Leading Companies) 13.2.1. New England Biolabs 13.2.2. Thermo Fisher Scientific 13.2.3. Takara Bio 13.2.4. Sigma-Aldrich 13.2.5. Illumina 13.2.6. Agilent Technologies 13.2.7. Promega 13.2.8. Jena Biosciences 13.2.9. Genetix Biotech Asia Pvt. Ltd. 13.2.10. Roche 13.2.11. Merck 13.2.12. Pfizer 13.2.13. Amgen 13.2.14. Vertex Pharmaceuticals 13.2.15. BioMarin Pharmaceutical 13.2.16. PerkinElmer 13.2.17. Abcam 13.2.18. Abbexa 13.2.19. Sisco Research Laboratories Pvt Ltd 13.2.20. Nippon Gene 14. Strategic Recommendations 15. About Us & Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオマス)の最新刊レポート
TechSci Research社のバイオマス分野での最新刊レポート
本レポートと同じKEY WORD(dna)の最新刊レポート
よくあるご質問TechSci Research社はどのような調査会社ですか?テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |